An in vivo study of cell-mediated immunity in human warts. Preliminary results

Open Access

1 July 1977

journal article
research article
Published by Medical Journals Sweden AB in Acta Dermato-Venereologica

Vol. 57 (4) , 317-319
https://doi.org/10.2340/0001555557317319

Abstract

Purified human papilloma virus (HPV) was used to study cell-mediated immunity (CMI) in patients with warts and in controls by means of the intradermal test (IDT). IDT was positive in 75% of patients with past history of warts, in 56% of patients presenting with warts, but in only 7% of controls. Immunofluorescent antibody levels were initially low and increased after injection of HPV antigen in all groups.